Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors. Adashek JJ, Menta AK, Reddy NK, Desai AP, et al. Mol Cancer Ther 2022;21:871-878.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Adashek JJ, Menta AK, Reddy NK, Desai AP, et al. Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors. Mol Cancer Ther 2022;21:871-878.
PMID: 35413124